ALBIREO PHARMA, INC.·4/A

Jan 27, 5:28 PM ET

Mattsson Jan 4/A

4/A · ALBIREO PHARMA, INC. · Filed Jan 27, 2023

Insider Transaction Report

Form 4/AAmended
Period: 2023-01-19
Mattsson Jan
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2023-01-19+55,000109,474 total
Footnotes (2)
  • [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 19, 2024, 6.25% of the shares every three months thereafter beginning on April 19, 2024 and ending on January 19, 2025, and 12.5% of the shares every three months thereafter beginning on April 19, 2025 and ending on January 19, 2026.
  • [F2]Represents 35,524 shares of common stock and 73,950 restricted stock units.

Documents

1 file
  • 4
    doc4a.xml

    FORM 4/A SUBMISSION